Mizuho Securities Upgrades Myriad Genetics (MYGN) to Buy
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $3.05 +0.66%
Rating Summary:
7 Buy, 19 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
7 Buy, 19 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Mizuho Securities upgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Buy with a price target of $34.00 (from $27.00).
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $28.30 yesterday.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $28.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- Rakus Co Ltd (3923:JP) PT Raised to JPY1,300 at Macquarie
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
